Detalhe da pesquisa
1.
Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosis.
Mult Scler
; 29(14): 1765-1775, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37786964
2.
Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study.
Mult Scler
; 24(2): 167-174, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273776
3.
Treatment satisfaction, adherence and behavioral assessment in patients de-escalating from natalizumab to interferon ß.
BMC Neurol
; 14: 38, 2014 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24576156
4.
A randomized pilot trial of oral prednisone taper vs placebo following iv methylprednisolone for multiple sclerosis relapses: Effects on adrenal function and clinical efficacy.
Mult Scler Relat Disord
; 50: 102867, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677411